期刊文献+

头孢丙烯分散片在中国健康人体的药代动力学 被引量:2

Pharmacokinetics of cefprozil dispersible tablets in Chinese healthy volunteers
原文传递
导出
摘要 目的研究头孢丙烯分散片在中国健康人体的药代动力学。方法 10名中国健康受试者,男女各半,单剂量口服头孢丙烯分散片500 mg。用高效液相色谱法同时测定血浆中顺式和反式头孢丙烯的浓度;用DAS 2.0药代动力学程序计算药代动力学参数。结果头孢丙烯的主要药代动力学参数:Cmax为(9.62±1.29)mg.L-1,Tmax为(1.30±0.35)h,t1/2(ke)为(1.32±0.15)h,V为(34.40±5.48)L,CL为(18.16±2.96)L.h-1,AUC0-10为(27.68±4.45)mg.h.L-1,AUC0-∞为(28.22±4.70)mg.h.L-1。结论头孢丙烯在人体内符合一级吸收的一室模型。 Objective To study the pharmacokinetics of cefprozil dispersible tablets in healthy volunteers.Methods Ten healthy volunteers(five males and five females) received 500 mg cefprozil dispersible tablets at a single oral dose.The concentrations of cis-cefprozil and trans-cefprozil in plasma were determined simultaneously by HPLC.The pharmacokinetic parameters were calculated by DAS program.Results After a single dose of 500 mg cefprozil dispersible tablets,the pharmacokinetic parameters for cefprozil were as follows: Cmax was(9.62±1.29) mg·L-1,Tmax was(1.30±0.35)h,t1/2(ke) was(1.32±0.15) h,V was(34.40±5.48) L,CL was(18.16±2.96) L·h-1,AUC0-10was(27.68±4.45) mg·h·L-1,AUC0-∞ was(28.22±4.70) mg·h·L-1.Conclusion Cefprozil was fitted to a one-compartment model with first absorption.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2012年第2期107-109,共3页 The Chinese Journal of Clinical Pharmacology
关键词 头孢丙烯 分散片 药代动力学 高效液相色谱法 cefprozil dispersible tablets pharmacokinetics high performance liquid chromatography
  • 相关文献

参考文献6

二级参考文献22

  • 1肖涛,张孝清,曹芳,田春梅,王锦堂.头孢丙烯的合成[J].中国医药工业杂志,2004,35(7):388-390. 被引量:13
  • 2张明发.头孢丙烯的抗菌药理与临床[J].上海医药,2005,26(3):111-117. 被引量:33
  • 3刘新宇,吴芳.头孢丙烯在下呼吸道细菌感染患者的药代动力学研究[J].药学实践杂志,2006,24(3):144-146. 被引量:5
  • 4Park TH, Kim JK, Jee JP, Park JS, Kim CK. HPLC method for simultaneous determination of cefprozil diastereomers in human plasma[J]. J Pharm Biomed Anal, 2004,36: 243 - 8.
  • 5Park TH, Kim JK, Jee JP, et al. HPLC method for simultaneous determination of cefprozil diastereomers in human plasma[ J]. J Pharm Biomed Anal, 2004 ;36:243 - 248.
  • 6Bonnet JP, Ginsberg D, Nolen TM,et al.Cefprozil vs.cefuroxime axetil in mild to moderate lower respiratory tract infections: A focus on bronchitis[J].Infect Med,1992, 9(Suppl E):48.
  • 7Fung Tomc JC, Huczko E, Stickle T,et al.Antibacterial activities of cefprozil compared with those of 13 oral cephems and 3 macrolides[J].Antimicrob Agents Chemother,1995,39:533.
  • 8Thornsberry C.Review of the in vitro antibacterial activity of cefprozil, a new oral antibiotic [J].Clin Infect Dis,1992,14(Suppl 2):189.
  • 9Barriere SL.Pharmacology and pharmacokinetics of cefprozil[J].Clin Infect Dis,1992, 14(Suppl 2):184.
  • 10Barbhaiya RH,Shukla VA,Gleason CR,et al.Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration[J].Antimicrob Agents Chemother,1990,34:1204.

共引文献16

同被引文献28

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部